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ABSTRACT 
There are two long-existing obstacles for cellulosic ethanol production in Saccharomyces 
cerevisiae. The first one is inefficient xylose utilization and the second one is sequential 
fermentation of glucose and xylose in engineered Saccharomyces cerevisiae. This study mainly 
focused on solving these two problems by using cutting edge synthetic biology tools.  
A phosphatase enzyme of unknown specificity in Saccharomyces cerevisiae, Pho13, 
plays a role in the transcriptional regulation of genes related to pentose phosphate pathway (PPP) 
and NADPH regeneration. It has been also reported that deletion of PHO13 (pho13Δ) in S. 
cerevisiae results in significantly improved xylose metabolism in engineered strains 
metabolizing xylose. However, it has not been elucidated whether the transcriptional activation 
caused by pho13Δ is associated with the metabolic changes favoring xylose fermentation. We 
investigated the global metabolic changes in response to pho13Δ to understand underlying 
mechanisms of the enhanced xylose fermentation upon pho13Δ. Among the 134 metabolites 
identified in cells grown on xylose, the concentration of sedoheptulose decreased by 98% in the 
pho13Δ mutant as compared to that of a parental strain. Sedoheptulose is not a common 
metabolite but a dephosphorylated form of sedoheptulose-7-phosphate (S7P), was also 
significantly decreased by pho13Δ. As S7P is a substrate of transaldolase (TAL1) in PPP, we 
hypothesized that TAL1 upregulation induced by pho13Δ might be responsible for the reduced 
accumulation of S7P and sedoheptulose, leading to improved xylose fermentation. We 
constructed various mutants overexpressing TAL1, and monitored their metabolic and phenotypic 
changes. Increased TAL1 expression levels were correlated with reduced sedoheptulose levels, 
and increased xylose consumption rates. While other transcriptional and metabolic changes 
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induced by pho13Δ were identified, we concluded that TAL1 upregulation that prevents 
sedoheptulose accumulation is the most important mechanism for improved xylose metabolism. 
Because of the strong inhibition of glucose to xylose at the transport level, transporter 
engineering is believed to be the prerequisite for achieving co-fermentation of glucose and 
xylose in Saccharomyces cerevisiae.  Platform strains with native major sugar transporters 
deletion and a robust xylose metabolism pathway are required for studying transporters for co-
fermentation. However, previously reported transporters studies were greatly restricted by their 
platform strains, which either suffered from the gene loss and genome rearrangement during the 
serial transporters deletion or their ineffective xylose metabolism pathway. In this study, we 
applied the CRISPR/Cas9 guided multiple-gene deletion technique to refactor a fast xylose-
fermenting Saccharomyces cerevisiae strain to a sugar-transport-deficient platform strain. With 
this platform strain, we investigated the xylose and glucose fermentation capacities of two 
mutant Gal2 transporters, Gal2-N376F and Gal2-N376V, and fulfilled their potentials of co-
fermentation of glucose and xylose. By the combination of two mutant Gal2 transporters, we 
constructed a co-fermenting mutant, which could ferment mixture of glucose and xylose as fast 
as the original sequential-fermenting strain. Moreover, we also set up the first Saccharomyces 
cerevisiae co-culture system to co-ferment glucose and xylose by using two yeast strains with 
opposite substrate selectivity. These studies demonstrated the efficiency of the CRISPR/Cas9 
based multiple-gene deletion technique and the feasibility of transporters engineering to enable 
co-fermentation of glucose and xylose in industrially relevant concentrations without 
compromising the fermentation rate and the ethanol yield.  
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CHAPTER 1: THESIS OVERVIEW 
1.1. Study for improving xylose metabolism 
In this study, we try to understand the mechanism of pho13Δ for improving xylose 
metabolism. Several independent studies reported that pho13Δ was beneficial for xylose 
metabolism (Kim et al., 2013c; Van Vleet et al., 2008). However, Pho13 is a non-specific 
phosphatase (Kaneko et al., 1989), which shows little connection to xylose metabolism. By using 
metabolomics approaches, we identified the most prominent metabolic changes caused by 
pho13Δ, which are the significant reduction of sedoheptulose-7-phosphate (S7P), an intermediate 
of PPP, and its dephosphorylation product, sedoheptulose. Interestingly, sedoheptulose-7-
phosphate is a substrate of transaldolase (Tal1), the expression of which increased after pho13Δ 
(Kim et al., 2014). Therefore, we developed the Cas9-guided promoter substitution method to 
modulate TAL1 expression level and examined its relation to the reduction of sedoheptulose-7-
phosphate and sedoheptulose. Finally, integration of metabolic changes with transcriptional 
responses revealed that TAL1 upregulation most significantly contributed to the metabolic and 
phenotypic changes induced by pho13Δ. 
 
1.2. Study for the co-fermentation of glucose and xylose 
In the second part of the study, HXT1-7 and GAL2 were deleted in an engineered 
Saccharomyces cerevisiae strain with an efficient xylose metabolism pathway, by using the 
Cas9-guided multiple-gene deletion technique. The resulting strain could not grow on both 
glucose and xylose while, by complementation with sugar transporters, the strain retained 
efficient xylose and glucose fermentation ability. This is the first study showing the benefit of the 
Cas9 technique for rapid construction of the sugar-transport-deficient Saccharomyces cerevisiae 
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strain. Furthermore, by introducing previous reported GAL2 (Farwick et al., 2014) mutants into 
our sugar-transport-deficient strain, we examined the characteristics of these two mutant 
transporters. Specifically, Gal2-N376V was able to support co-fermentation of glucose and 
xylose solely, while overexpression of Gal2-N376V in our sugar-transport-deficient strain 
generated a mutant strain with strong selectivity towards xylose, which was applied to build a co-
culture system for the co-fermentation of glucose and xylose. Finally, by the combination of 
these two transporters, we achieved co-fermentation of glucose and xylose with the similar rate 
as compared to sequential fermentation by the parental strain. 
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CHAPTER 2: PHO13 DELETION-INDUCED TRANSCRIPTIONAL ACTIVATION 
PREVENTS SEDOHEPTULOSE ACCUMULATION DURING XYLOSE 
METABOLISM IN ENGINEERED SACCHAROMYCES CEREVISIAE 
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2.1. Introduction  
Saccharomyces cerevisiae is one of the most widely used industrial microorganisms 
because of its excellent fermentation performance under various stress conditions; it can also be 
easily genetically engineered (Jeffries and Jin, 2004; Olsson and Nielsen, 2000). To facilitate the 
anticipated transition of current crop-based bioprocesses to sustainable cellulosic processes (Park 
et al., 2001), metabolic engineering approaches to develop microorganisms capable of 
fermenting xylose efficiently and rapidly have been undertaken (Kim et al., 2013b). While 
xylose is one of the two major sugars in most cellulosic biomass hydrolysates, S. cerevisiae 
strains which are currently used for bioethanol production from corn and sugarcane cannot 
ferment xylose.  In order to enable xylose fermentation in S. cerevisiae, heterologous xylose-
assimilating pathways converting xylose to xylulose-5-phosphate, an intermediate of the native 
pentose phosphate pathway (PPP), were introduced into S. cerevisiae (Billard et al., 1995; Brat et 
al., 2009; Hahn-Hagerdal et al., 2007; Ho et al., 1998; Jeffries and Jin, 2004; Karhumaa et al., 
2007a; Karhumaa et al., 2007b; Kim et al., 2013b; Lee et al., 2014b; Takuma et al., 1991; 
Tantirungkij et al., 1993). 
While initial attempts confirmed the feasibility of fermenting xylose through introducing 
the heterologous xylose metabolic pathways, yields and productivities of ethanol from xylose 
were far from commercial use needs. Numerous follow-up studies identified extra genetic 
perturbations that enhanced xylose fermentation by engineered S. cerevisiae (Diao et al., 2013; 
Hahn-Hagerdal et al., 2007; Hasunuma et al., 2014; Kim et al., 2013b; Kim et al., 2013c; Kuyper 
et al., 2005a; Lee et al., 2014b; Matsushika et al., 2009; Ni et al., 2007). The step most 
speculated to be limiting for efficient xylose metabolism was PPP, where xylulose-5-phosphate 
is metabolized into intermediates of glycolysis, fructose-6-phosphate and glyceraldehyde-3-
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phosphate (Diao et al., 2013; Kim et al., 2013b; Matsushika et al., 2009). Indeed, overexpression 
of genes in the non-oxidative PPP significantly improved the rate of xylose metabolism 
(Hasunuma et al., 2014; Kuyper et al., 2005a; Latimer et al., 2014; Lu and Jeffries, 2007; 
Matsushika et al., 2012). Among the PPP genes, TAL1 is widely accepted to be the most 
effective target gene for improving xylose metabolism (Kim et al., 2013b; Latimer et al., 2014; 
Lee et al., 2014b; Ni et al., 2007; Walfridsson et al., 1995).   
In addition to the aforementioned rational approach, laboratory evolution and random 
mutagenesis have been performed to overcome unknown limiting factors of xylose metabolism 
(Kim et al., 2013c; Kuyper et al., 2005b; Liu and Hu, 2010; Ni et al., 2007; Peng et al., 2012; 
Sanchez et al., 2010; Sonderegger and Sauer, 2003; Tomitaka et al., 2013; Wisselink et al., 
2009). At least two independent studies observed that evolved mutants capable of metabolizing 
xylose efficiently acquired a mutation in the PHO13 gene, which encodes an - alkaline 
phosphatase (Kim et al., 2013c; Van Vleet et al., 2008). Several follow-up studies confirmed that 
deletion of PHO13 (pho13Δ) significantly improved xylose fermentation without impairing 
glucose fermentation capability (Fujitomi et al., 2012; Kaneko et al., 1989; Kim et al., 2013c; 
Kim et al., 2014; Lee et al., 2014b; Li et al., 2014; Ni et al., 2007; Sakihama et al., 2015; Van 
Vleet et al., 2008).  
A very recent study reported that the Pho13 enzyme is involved in transcriptional 
regulation of the PPP (Kim et al., 2014). Transcriptome analysis revealed that nine genes were 
significantly upregulated by pho13Δ and six of them were directly related to either PPP (SOL3, 
GND1, TAL1) or NADPH regeneration (GCY1, GOR1, YEF1). Interestingly, the transcription 
factor STB5, activated under oxidative stress, was necessary for the transcriptional changes 
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induced by pho13Δ.  However, neither the exact mechanism of transcriptional regulation nor the 
biological significance of Pho13 has been entirely understood.  
Using metabolomics approaches, the present study examined metabolic changes elicited 
by pho13Δ in engineered yeast cells grown on xylose-containing medium. Notably, we detected 
significantly lowered levels of sedoheptulose-7-phosphate (S7P), an intermediate of PPP, and its 
dephosphorylation product in the pho13Δ mutant as compared to the parental strain. Moreover, 
integration of metabolic changes with transcriptional responses revealed that TAL1 upregulation 
most significantly contributed to the metabolic and phenotypic changes induced by pho13Δ. 
 
2.2. Materials and methods 
2.2.1 Strains and culture conditions 
All strains and plasmids used in this study were listed in Table 2.3. Yeast strains were 
first grown in 5 mL of YP medium (10 g/L yeast extract, 20 g/L Bacto peptone) containing 20 
g/L glucose aerobically at 30°C for 24 hours. Then it was harvested and washed twice with 
sterile water. For fermentation experiments, the initial cell densities were adjusted to around OD 
= 1 (optical density at 600 nm), which is about 0.47 g/L dry cell weight. Fermentation 
experiments were conducted under oxygen-limited condition in 125 mL flasks containing 25 mL 
medium at 30°C and 100 rpm.  
 
2.2.2. Metabolite extraction 
Metabolite extraction was conducted with slight modifications to previously described 
(Kim et al., 2013a). Briefly, cells were collected by fast vacuum-filtering 1 mL of yeast strains at 
mid-exponential growth phase (dependent on cell density) through a 30 mm diameter nylon 
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membrane filter (0.45 μm pore size; Whatman, Piscataway, NJ) and then washed with 5 mL of 
water. The filter containing the cells were quickly submerged into 10 mL of acetonitrile/water 
mixture (1:1, v/v) at -20°C and the extraction mixture of cells and solvent was then transferred 
into liquid nitrogen. The extraction mixture was thawed on ice and vortexed for 3 min. After 
centrifuging at 16100 g for 5 min at 4°C, the supernatant was collected and concentrated until 
completely dried in a vacuum concentrator (Labconco; Kansas City, MO). 
Prior to GC-TOF/MS analysis, the metabolite samples were derivatized by 
methoxyamination and trimethylsilylation. For methoxyamination, 5 μL of methoxyamine 
hydrochloride in pyridine (40 mg/mL; Sigma-Aldrich, St. Louis, MO) was added to the samples 
and incubated for 90 min at 30°C. For trimethylsilylation, 45 μL of N-methyl-N-
trimethylsilyltrifluoroacetamide (Fluka, Buchs, Switzerland) was added to the samples and 
incubated for 30 min at 37°C. Finally, fatty acid methyl ester mixture (C08 – C30) was added to 
the derivatized samples as the internal retention index marker.  
 
2.2.3. GC-TOF/MS and statistical analysis 
GC-TOF MS analysis was conducted using an Agilent 7890B GC equipped with a 
Pegasus HT TOF MS (Leco, St. Joseph, MI). A 1 µL aliquot of derivatized samples was injected 
into the GC in a splitless mode and separated on an RTX-5Sil MS column (30 m × 0.25 mm, 
0.25 μm film thickness; Restek, Bellefonte, PA) with an integrated guard column (10 m × 0.25 
mm, 0.25 μm film thickness; Restek, Bellefonte, PA). The initial oven temperature was set at 
50°C for 1 min, and then ramped at 20°C/min to a final temperature of 330°C, held for 5 min. 
The temperatures of ion source and transfer line were set at 250°C and 280°C, respectively. An 
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electron impact of 70eV was used for ionization. The mass spectra of metabolites were obtained 
in the mass range of 85 – 500 m/z at an acquisition rate 17 spectra/s. 
The preprocessed raw data were obtained using LECO Chroma TOF software (ver. 4.50; 
St. Joseph, MI) and the further processed data were obtained using BinBase, in-house database 
(Kim et al., 2013a; Lee do and Fiehn, 2008; Lee et al., 2014a). The statistical analysis of 
processed data was performed using Statistica (ver. 7.1; StatSoft, Tulsa, OK) and 
MultiExperiment Viewer (Dana-Farber Cancer Institute, Boston, MA) (Denkert et al., 2008; 
Saeed et al., 2006) 
 
2.2.4. NMR analysis 
Metabolite extract samples were dissolved in 0.5 mL of NMR buffer (0.5 mL D2O with 
100 mM sodium phosphate and 0.02 mM DSS as internal standard). All NMR spectra were 
recorded at 25°C on a Bruker Avance 600 MHz using a 5 mm TXI Cryoprobe. 1D 1H NMR 
spectra were acquired using a standard Bruker noesypr1d pulse sequence. Experiments were 
acquired with 1024 scans of 64K data points with a spectral width of 8 kHz, an acquisition time 
of 3.9 s, and a recycle delay of 1 s.  Metabolite identification and assignment were performed 
with the support of 2D NMR experiments: total correlation spectroscopy (TOCSY); 
heteronuclear single quantum correlation (HSQC); and heteronuclear multiple bond correlation 
(HMBC). Interpretation was done with the assistance of information from the Biological 
Magnetic Resonance Bank (BMRB) (Ulrich et al., 2008) and Chenomx NMR software (version 
7.6) (Chenomx). Bruker Topspin 3.2 software was used to process and analyze all spectra. 
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2.2.5. Protein expression and purification 
The PHO13 gene was amplified from S. cerevisiae D452-2 genomic DNA and ligated 
with the pETDuet-1 plasmid using BamHI and SalI restriction enzyme sites, resulting in the 
pETDuet-1_ScPHO13 plasmid.  E. coli BL21 transformant of the plasmid was grown in LB 
broth with 100 µg/mL ampicillin and the Pho13 recombinant protein with N-terminal His-tag 
was purified by Ni-NTA affinity column following the manufacturer’s instructions (Qiagen 
30600, Valencia, CA). 
 
2.2.6. Phosphatase assay 
The protein concentration of purified Pho13 solution (1.73 mg/mL) was determined by 
BCA protein assay kit (Pierce, Rockford, IL).  Phosphatase activity was tested in 200 µL of 
reaction solution containing 1 µg enzyme, 0.1 mM substrate, and 50 mM HEPES-K buffer (pH 
7.5).  After incubation for 30 min at 25ºC, 80 uL of the reaction solution or diluted one was used 
to quantify the amount of free phosphates by Malachite green phosphate assay kit as the 
manufacturer’s instructions (BioAssay Systems POMG-25H, Hayward, CA).  Reaction solution 
without a substrate served as a negative control and free phosphate contamination in each 
substrate solution has been subtracted from the total phosphate concentration.  Phosphatase 
activity was expressed as µmol/min/mg. 
 
2.2.7. Strain construction using the CRISPR-Cas9 based genome editing system (using 
TAL1 promoter substitution as an example) 
The pRS41N plasmid harboring the Cas9 cassette was constructed by switch the TRP1 
selection marker of p414-TEF1P-Cas9-CYC1T (Plasmid #43802, Addgene Inc) with NAT1. 
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For construction of guide RNA (gRNA) expressing plasmid, vector pRS42K plasmid was 
linearized with EcoRV, then treated with rSAP and finally ligated with different singular gRNA 
expressing cassette. For designing the gRNA, a PAM (NGG) sequence around 57 bp upstream of 
the starting codon of TAL1 was chosen and then 20 bp target sequence upstream of the PAM 
sequence was determined for guide RNA. The 20   bp guide sequences were designed as 
described in Table 2.4. And the gRNA cassettes were obtained from IDT (Coralville, IA) as 
gBlocks gene fragments with 5’ phosphorylated ends.  After guided RNA plasmids were 
obtained, they were treated with BamHI and SalI to check the presence of insert. 
Around 500 to 700 bp promoter regions of four target genes were flanked with 
homologous sequence of the promoter region of TAL1 as PCR amplified as donors. When 
determining the optimal length for the promoter, introducing ORFs from other genes abutting our 
target promoters were avoided. All the donor DNA was amplified by using primer as shown in 
Table 2.5. The primers for donor amplification were totally 60 bp long with around 20 bp 
homologous region of the template target promoter and round 40 bp homologous region from the 
TAL1 promoter.  
The pRS41N-Cas9 plasmid was introduced into parental strain SR7 and the selected 
colonies were plated on YPD agar containing 120 µg/mL nourseothricin (clonNAT). Then SR7 
pRS41N-Cas9 strain was transformed with both guide RNA plasmid and donor DNA. Next 
colonies were selected from YPD plate containing both 120 µg/mL nourseothricin and 300 
µg/mL geneticin (G418) and confirmed by yeast colony PCR and sequencing with the primers 
mentioned in Table 2.5, according to the presence of right insertion. 
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2.2.8. RT-qPCR 
RNA was extracted from cells growing in the exponential phase as previously described 
(Kim et al., 2014). cDNA was generated from 1 µg purified RNA by using iScript cDNA 
Synthesis Kit (Bio-Rad, Hercules, CA, USA) in a 20 µL reaction. The producing solution was 
diluted to 100 µL, and 5 µL of diluted solution was used for quantitative PCR by using iQ SYBR 
Green Supermix (Bio-Rad, Hercules, CA, USA) in a 96-Well plate. All the primers (Table 2.5) 
for qPCR were designed by using the IDT PrimerQuest program and obtained from IDT. The 
qPCR was conducted on a LightCycler 480 apparatus (Roche, Basel, Switzerland). The ACT1 
gene was used as a housekeeping gene. The comparative threshold cycle (CT) method (the ∆∆CT 
method) was used to calculate the RT-qPCR results (Kim et al., 2014). 
 
2.3. Results 
2.3.1. NMR analysis of the global metabolic response upon pho13Δ 
An engineered S. cerevisiae strain capable of fermenting xylose at a suboptimal level 
(SR7) and its PHO13 deletion mutant (SR7 pho13∆) were constructed in our prior study (Kim et 
al., 2013c). When the two engineered strains were grown on xylose-containing medium as the 
sole carbon source, the pho13∆ mutant grew 5- fold faster than the control strain (Kim et al., 
2013c). To investigate the metabolic changes resulting from pho13Δ, we performed metabolic 
profiling of the yeast intracellular metabolites using NMR. The NMR spectra showed that there 
were substantial differences between the SR7 strain and the pho13∆ mutant, as seen in the 1D 
aliphatic region spectra (Fig. 2.8) and on comparing their 2D HSQC spectra (Fig. 2.1A and 
2.1B). Among the signals that contribute to the differences, those at δH 4.29 and 4.07 ppm were 
the most prominent in the metabolites from the SR7 strain (Fig. 2.8A), whereas the 2D HSQC 
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spectrum showed five dominant peaks at δH/δC 4.29/78.1, 4.07/78.5, 3.83/75.2, 3.75/83.0, and 
3.57/65.3 ppm (Fig. 2.1A). The structure of the compound was resolved by interpreting the two-
dimensional HSQC, TOCSY, and HMBC spectra, as well as reviewing the existing literature on 
NMR chemical shifts (Ceusters et al., 2013).  The TOCSY spectrum revealed that the five 
additional correlations evident in HSQC are within the same spin system, and the HMBC 
experiment added long-range CH correlations to an anomeric carbon at δC 104.8 ppm. Based on 
these data, the signals were attributable to α-furanose form of sedoheptulose. The spectra show 
that sedoheptulose level significantly decreases in the pho13∆ mutant. 
 
2.3.2. GC-TOF/MS analysis of the global metabolic response upon pho13Δ 
For capturing the metabolic changes at higher resolution, the intracellular metabolites of 
the SR7 strain and the pho13∆ mutant were analyzed by GC-TOF/MS after derivatization. A 
total of 134 metabolites were identified and subjected to hierarchical clustering analysis (HCA) 
and principal component analysis (PCA). Six replicates of the control strain and the pho13∆ 
mutant were clearly discriminated as clustered in the heat map (Fig. 2.9), and as shown in the 
score plot (Fig. 2.1C). Based on principal component (PC) 1, the levels of 70 metabolites 
including sedoheptulose and sedoheptulose-7-phosphate (S7P) were low in the pho13∆ mutant, 
whereas the levels of 64 other metabolites detected were higher compared to the corresponding 
metabolite levels in the control strain (SR7). The top 30 metabolites contributing toPC1 and PC2 
were listed in Table 2.2. A 98% reduction in sedoheptulose was the most prominent change 
induced by pho13Δ (Fig. 2.1D), corroborating the results from the NMR analysis. 
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2.3.3. Manipulation of TAL1 expression levels using the transcriptome- and Cas9-guided 
promoter substitution technique 
Significant reduction of sedoheptulose (98%) and S7P (83%) suggested that related 
metabolic pathways are affected by pho13Δ.  Since S7P is a substrate of transaldolase (TAL1) in 
PPP, we reasoned that transaldolase activity might be limiting in the control strain (SR7) when 
metabolizing xylose as compared to the pho13∆ mutant. Indeed, TAL1 is one of the genes that 
are up-regulated by pho13Δ, as reported in our previous study (Kim et al., 2014).   
To test the hypothesis, various xylose-fermenting strains with different TAL1 expression 
levels were constructed by replacing the original promoter of TAL1 with promoters exhibiting 
discrete levels of transcriptional activity. In order to select the promoters which will be used to 
replace the original promoter of TAL1, we analyzed RNA-seq data published previously (Kim et 
al., 2014), and identified genes that were constitutively expressed under both glucose and xylose 
conditions. Based on the abundances of their transcripts, we selected four genes showing 
approximately 2-fold (RPS13), 3-fold (HFF1), 8-fold (TEF2), and 17-fold (CCW12) higher 
expression levels as compared to the native TAL1 (Table 2.1). Promoter regions of the selected 
set of genes were PCR-amplified as donor DNA to repair a double strand break upstream of 
TAL1 created by an RNA-guided DNA endonuclease (Cas9) (see Materials and Methods; Fig. 
2.2A). Four resulting strains with the replaced promoters of TAL1 have genetic backgrounds 
identical to the original SR7 strain because Cas9-based genome editing is highly-specific to a 
designed target. To confirm differential expression of TAL1 via the Cas9-guided promoter 
substitution strategy, TAL1 expression levels in the four promoter-replaced mutants and the 
original SR7 strain were measured by RT-qPCR. As shown in Table 2.1 and Figure 2.2B, the 
four mutants had elevated expression levels of TAL1 with marginal differences compared with 
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the expected values: 4-fold (RPS13P-TAL1), 3-fold (HFF1P-TAL1), 9-fold (TEF2P-TAL1), and 
20-fold (CCW12P-TAL1). Moreover, theoretical promoter strength (relative to transcript 
abundance of the corresponding gene) and the empirical values (transcript abundance of the 
engineered TAL1 gene) were well correlated (Fig. 2.10). 
 
2.3.4. Increase in TAL1 expression leads to lower sedoheptulose accumulation and 
improved xylose metabolism 
To investigate phenotypic and metabolic changes in response to the elevated expression 
levels of TAL1, xylose fermentation profiles by the four mutants and the parental strain (SR7) 
were examined. Cell growth, xylose consumption as well as ethanol production improved as the 
expression levels of TAL1 increased (Fig. 2.3). Moreover, intracellular concentrations of 
sedoheptulose and S7P were negatively correlated with TAL1 expression levels (Fig. 2.4A and 
Fig. 2.4B). This result suggests that overexpression of TAL1 might lead to decrease in 
sedoheptulose accumulation and increase in xylose fermentation of engineered S. cerevisiae. 
Taken together with previous reports, we concluded that transaldolase (encoded by TAL1) was 
indeed the primary rate-limiting step of xylose metabolism in engineered S. cerevisiae, and the 
limitation could be overcome by pho13Δ via transcriptional activation of TAL1. 
However, the extent of the metabolic changes induced by pho13Δ could not be attributed 
to the same level of TAL1 upregulation alone. Specifically, the pho13∆ mutant showed only 3-
fold upregulation of TAL1 but it exhibited significantly higher xylose consumption rates and 
lower intracellular sedoheptulose concentrations than the mutant strain with 4-fold TAL1 
overexpression (SR7 RPS13P-TAL1), which was created by the promoter replacement strategy 
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(Table 2.1). Excessive levels of TAL1 overexpression (9-fold and 20-fold) were necessary to 
achieve the xylose consumption rates as high as the pho13Δ strain (Fig. 2.4B). 
 
2.3.5. GND1 overexpression does not augment xylose metabolism  
As the equivalent overexpression of TAL1 by promoter replacement did not lead to 
similar performance of xylose fermentation by the pho13∆ mutant, we hypothesized that other 
PPP genes upregulated by pho13Δ might be responsible for pho13Δ-induced metabolic and 
phenotypic changes: i.e. reduced sedoheptulose accumulation and improved xylose metabolism. 
Thus, we investigated the overexpression effect of GND1, which showed the highest 
upregulation (15-fold) in response to pho13Δ among all PPP genes (Kim et al., 2014). A strain 
overexpressing GND1 was constructed by changing its promoter to TPI1P (see Materials and 
Methods), and the resulting strain (SR7 TPI1P -GND1) exhibited a 6-fold increase in GND1 
expression compared with the control (Fig. 2.5A). However, no positive phenotypic changes 
were observed in the GND1-overexpressing mutant during growth on xylose-containing medium 
(Fig. 2.5B and C). This result suggests that GND1 upregulation alone does not yield the 
metabolic changes that are observed in the pho13Δ strain.  
Interestingly, when we measured the PP pathway genes expression levels after TAL1 
overexpression, we found that ZWF1, SOL3 and TKL1 had the similar expression levels in TAL1 
overexpression strain (SR7 CCW12p-TAL1) and parental strain, in both glucose and xylose 
condition. However, GND1 expression level was induced in xylose condition but not glucose 
condition (Fig. 2.11). 
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2.3.6. Phosphatase activity of Pho13 on various substrates 
As the upregulation of PPP genes did not sufficiently explain the enhanced xylose 
fermentation upon pho13Δ, we hypothesized that the catalytic activity of Pho13 might be 
detrimental to xylose metabolism in engineered S. cerevisiae. Because Pho13 is known as 
alkaline phosphatase, we examined its phosphatase activity on various intermediates of xylose-
metabolic pathway (Fig. 2.6). Interestingly, Pho13 exhibited non-specific phosphatase activity on 
all intermediates of PPP including S7P, while its phosphatase activity on glycolytic intermediates 
(glucose-6-phosphate and fructose-6-phosphate) was negligible. This result suggests that Pho13 
might be responsible for the accumulation of sedoheptulose by dephosphorylating S7P during the 
xylose fermentation by the SR7 strain. Owing to low substrate specificity, it was speculated that 
Pho13 phosphatase activity on S7P might be significant only when S7P levels are extremely high 
during xylose metabolism in a strain with limited transaldolase activity. 
 
2.4. Discussion 
Application of omic approaches has become immensely popular in the area of metabolic 
engineering (Dromms and Styczynski, 2012; Han et al., 2011; Park et al., 2005; Vemuri and 
Aristidou, 2005). The present study is another example of using metabolomics for strain 
development, especially for engineering xylose-fermenting S. cerevisiae. In previous studies, 
glucose- and xylose-metabolizing engineered yeast strains were compared using metabolomics 
(Matsushika et al., 2013; Senac and Hahn-Hagerdal, 1990). Numerous differences in catalytic 
and signaling pathways were identified between glucose and xylose conditions. In this study, we 
captured metabolic differences between an efficient xylose-fermenting strain (SR7 pho13Δ) and 
a poor xylose-fermenting strain (SR7) under the same conditions. Both analytical methods— 
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NMR or GC-TOF/MS—used identified sedoheptulose as the most significantly variable 
metabolite between the two differently performing strains. The results suggested that the most 
limiting step of xylose metabolism might be transaldolase (encoded by TAL1). Indeed, 
overexpression of TAL1 in the low-efficiency strain resulted in dramatic improvement of xylose 
fermentation capability, comparable to that of the high-efficiency strain. Although the TAL1 is 
already known to be an important overexpression target for improving xylose metabolism, our 
study revealed three novel findings relevant to this field of study.   
First, the present study was a follow up to our previous evolutionary engineering work 
(Kim et al., 2013c), and we successfully undertook systems biology approaches to identify 
molecular mechanisms responsible for the evolved phenotypes. Evolutionary engineering is one 
of the most effective metabolic engineering strategies as demonstrated in many studies (Farwick 
et al., 2014; Kim et al., 2013c; Kuyper et al., 2005b; Lee et al., 2014b; Liu and Hu, 2010; Peng et 
al., 2015; Peng et al., 2012; Sanchez et al., 2010; Sonderegger and Sauer, 2003; Wisselink et al., 
2009). Hence, the best xylose-fermenting strains developed thus far have been isolated after 
long-term exposure to xylose in either a chemostat or consecutive batch cultures (Kim et al., 
2013c; Kuyper et al., 2005b; Lee et al., 2014b; Liu and Hu, 2010; Runquist et al., 2010; Sanchez 
et al., 2010; Zhou et al., 2012). However, not many studies have attempted to elucidate a detailed 
mechanism for improved phenotypes of their evolved mutants. The functions of the gene target 
(PHO13) that was identified by genome sequencing of our evolved mutant (Kim et al., 2013c) 
were investigated using transcriptomics (Kim et al., 2014) and metabolomics, which revealed its 
novel transcriptional and metabolic activities. We concluded that Pho13 functions as an 
inhibitory factor in the xylose metabolic pathway as illustrated in Figure 2.7. 
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Second, the novel biological functions of Pho13 was discovered in our work because the 
transcriptional and metabolic activities were significant enough to be observed when cells were 
poorly metabolizing xylose. We think that poor xylose metabolism might mimic certain 
environmental stresses such as NADPH limitation or sugar phosphate accumulation; thus, 
understanding these may elucidate the biological significance of Pho13. 
 Third, we developed transcriptome- and Cas9-guided promoter substitution technology to 
study the metabolic impact of transcriptional regulation of a target gene (TAL1) at high 
resolution. Previously, manipulating gene expression was limited to the use of single or multi 
copy plasmids with only a few constitutive promoters. However, episomal overexpression often 
results in pleiotropic phenotypes owing to selection pressure and/or metabolic burden. In 
contrast, our promoter substitution approach uses marker-free genome editing technology 
mediated by Cas9 (DiCarlo et al., 2013; Jakociunas et al., 2015; Mans et al., 2015; Ryan and 
Cate, 2014; Zhang et al., 2014). Because selection pressures are only required during a genome 
editing process, once the genome has been mutated, mutants can be tested under the same 
conditions as their corresponding wild types. Moreover, using the transcriptomic data 
representative of the strength of each promoter, it was possible to select a wide range of 
promoters to accurately manipulate expression levels of the target gene, as proven in TAL1’s 
case (Table 2.1). The expression levels of TAL1 increased by 2–20 folds compared to the wild 
type strain, and the approach helped us to demonstrate a linear correlation between TAL1 
expression levels and xylose fermentation capability. 
Our study investigated metabolic responses to pho13Δ in S. cerevisiae. Based on the 
transcriptional changes induced by pho13Δ, we concluded that TAL1 upregulation is primarily 
initiates the metabolic changes observed in the pho13Δ mutant. These changes ultimately result 
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in significantly improved xylose metabolism in strains expressing a heterologous xylose 
pathway. 
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2.5. Tables 
Table 2.1. Comparison of TAL1-overexpressing mutants with the pho13∆ mutant 
Gene expression levels measured by RNA-seq 
 
Expression levels of engineered TAL1 and its impact on xylose metabolism 
Gene 
Glucose  
(RPKM) 
Xylose 
(RPKM) 
Relative 
promoter 
strength 
(xylose) 
 
Strains 
Relative 
expression  
levels of TAL1# 
Relative 
concentration  
of S7P* 
Relative 
concentration 
of sedoheptulose 
Specific xylose 
consumption  
rate (h-1) 
TAL1 844 906 1 
 
Control 1 1.000±0.850 1.000±0.261 0.129±0.003 
HFF1 2773 3031 3.35 
 
HFF1p-TAL1 3.47 ± 0.20 - - 0.257±0.028 
RPS13 3303 2343 2.59 
 
RPS13p-TAL1 3.97 ± 0.09 0.910±0.694 0.182±0.098 0.329±0.028 
TEF2 6693 7059 7.79 
 
TEF2p-TAL1 8.65 ± 1.45 0.169±0.134 0.005±0.002 0.405±0.003 
CCW12 14449 15729 17.36 
 
CCW12p-TAL1 20.07 ± 1.23 0.121±0.088 0.004±0.001 0.434±0.001 
    
 
pho13∆ 2.99±0.07 0.172±0.117 0.019±0.006 0.442±0.013 
#Measured by RT-qPCR using cells grown on xylose-containing medium 
*Sedoheptulose-7-phosphate 
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2.6. Figures 
  
Figure 2.1. Metabolic changes induced by pho13Δ. Partial HSQC spectra of the (A) control strain 
and the (B) pho13Δ mutant obtained from NMR analysis shows significant reduction of 
sedoheptulose by pho13Δ. (C) Principle component (PC) analysis of metabolite profiles 
measured by GC-TOF/MS also shows clear differences between the two strains (score plot), and 
(D) sedoheptulose was significantly low in the pho13Δ mutant. sed, sedoheptulose; tre, trehalose; 
Thr, threonine. 
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Figure 2.2. Increased TAL1 expression levels in the mutants constructed using the transcriptome- and Cas9-guided promoter 
substitution method. (A) An illustration of our promoter substitution strategy; four promoters with different strengths were selected 
based on transcriptome data, and the selected promoters were inserted upstream of the TAL1 gene using the Cas9 genome editing 
technique. (B) Changes in TAL1 expression levels induced by promoter substitution; cells were grown on xylose-containing medium, 
and TAL1 expression levels of the mutants and the control strain were measured by RT-qPCR. Error bars indicate standard deviations 
of three biological replicates. 
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Figure 2.3. Increased rate of xylose metabolism in TAL1-overexpressing mutants compared with the control strain (SR7). (A) Cell 
growth, (B) xylose consumption, and (C) ethanol production were compared. Error bars indicate standard deviations of three 
biological replicates. 
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Figure 2.4. Metabolic and phenotypic changes due to TAL1 overexpression. (A) Reduction in intracellular accumulation of 
sedoheptulose-7-phosphate (S7P) and sedoheptulose in TAL1-overexpressing mutants.  The mean of 6 biological replicates represents 
the metabolite intensity of the mutants relative to that of the control strain (100%). (B) Effect of TAL1 expression levels on S7P 
accumulation and xylose consumption rate. TAL1 expression level negatively correlates with S7P accumulation (black dotted line) but 
positively correlates with the xylose consumption rate (blue solid line). 
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Figure 2.5. Phenotypes of the mutant overexpressing GND1. (A) Increased expression level of the GND1 gene in the GND1-
overexpressing mutant was confirmed by RT-qPCR. The mutant was constructed by the transcriptome- and Cas9-guided promoter 
substitution strategy. Growth and xylose consumption of the (B) control strain and the (C) GND1-overexpressing mutant were 
compared. 
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Figure 2.6. In vitro phosphatase activity of Pho13 on various sugar phosphates. X5P, xylulose-5-
phosphate; Ru5P, ribulose-5-phosphate; R5P, ribose-5-phosphate; S7P, sedeheptulose-7-
phosphate; E4P, erythrose-4-phosphate; G6P, glucose-6-phosphate; F6P, fructose-6-phosphate. 
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Figure 2.7. Schematic of a putative mechanism for sedoheptulose accumulation during xylose 
metabolism in engineered S. cerevisiae. 
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2.7. Supplementary materials 
Table 2.2. List of major metabolites identified by principle component (PC) analysis 
* Fold change was calculated based on the ratio of metabolite intensity of the mutant and the  
PC1   PC2  
Metabolite Loading Fold change* Metabolite Loading Fold change 
2-Ketoadipate 0.959 2.187 Carnitine −0.596 1.009 
Sedoheptulose 0.915 −53.324 Palmitic acid 0.822 1.041 
Erythrose 4-phosphate 0.906 2.625 Pelargonic acid 0.817 1.013 
Benzoate 0.867 1.453 5-Aminovalerate 0.805 1.140 
Urea 0.866 2.467 Trehalose 6-phosphate 0.803 1.488 
Inosine 0.780 1.915 Octadecanol 0.803 1.026 
Cytindine 5-monophosphate 0.761 −4.634 Myristic acid 0.770 1.039 
Cholic acid 0.755 2.315 Xylitol 0.765 −1.446 
Adipate 0.725 1.411 Threose 0.758 −1.044 
Citrate 0.711 3.453 Stearic acid 0.753 1.073 
Threitol 0.708 1.408 Melibiose 0.725 1.071 
Pyruvate 0.670 1.520 Terephtalate 0.703 −1.021 
Sedoheptulose 7-phosphate 0.683 −5.873 Lignoceric acid 0.694 1.025 
Methionine 0.688 1.352 Malonate 0.693 1.045 
Adenosine −0.944 1.616 Xylose 0.681 1.104 
Ribulose 5-phosphate −0.925 2.329 Linolenic acid 0.613 1.158 
Mannose 6-phosphate −0.915 5.408 Methylthioadenosine 0.610 1.151 
Cellobiose −0.900 1.357 Trehalose 0.596 1.339 
Glutamine −0.889 1.603 1-Monopalmitin 0.593 1.148 
Uridine −0.879 −1.904 Cysteine −0.832 1.001 
Galactonate −0.873 1.865 Mannose −0.717 1.111 
Malate −0.866 1.337 Isoleucine −0.683 1.064 
Xylulose −0.852 1.315 Glycine −0.665 1.068 
Xanthine −0.837 −1.144 Tyrosine −0.651 1.082 
Myo-inositol −0.835 −1.286 3-Phenyllactate −0.643 1.287 
Lactose −0.806 1.438 Putrescine −0.641 1.682 
Glucose 6-phosphate −0.785 2.321 Glycerol −0.635 −1.160 
Lactulose −0.784 8.563 Dihydroxyacetone −0.633 1.946 
Fumarate −0.773 1.367 Asparagine dehydrated −0.605 1.031 
Uracil −0.760 −1.238 Threonine −0.604 1.209 
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metabolite intensity of the wild type. If the ratio was less than 1, its negative reciprocal was used.
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Table 2.3. List of plasmids and strains used in the study 
Plasmid or Strain Description Reference 
Plasmids   
pETDuet-1_ScPHO13 A bacterial plasmid for the expression of S. cerevisiae PHO13 with a N-terminal His-tag This study 
p41N-Cas9 A single-copy plasmid containing Cas9 and a natMX marker  This study 
p42K-gRNA-TAL1 A multi-copy plasmid containing a guide RNA and a Geneticin marker  This study 
p42H-gRNA-GND1 A multi-copy plasmid containing a guide RNA and a Hygromycin B marker  This study 
Strains   
E. coli ScPHO13 E. coli BL21 pETDuet-1_ScPHO13 This study 
SR7 S. cerevisiae D452-2 with a xylose pathway (S. stipitis XYL1, XYL2, and XYL3) 
(Kim et al., 
2013c) 
SR7 pho13∆ SR7 pho13::kanMX 
(Kim et al., 
2013c) 
SR7 p41N-Cas9 SR7 with Cas9 protein expressing plasmid This study 
SR7 HFF1P-TAL1 SR7 with insertion of a HHF1 promoter insertion in front of TAL1 gene This study 
SR7 RPS13P-TAL1 SR7 with insertion of a RPS13 promoter insertion in front of TAL1 gene This study 
SR7 TEF2P-TAL1 SR7 with insertion of a TEF2 promoter insertion in front of TAL1 gene This study 
SR7 CCW12P-TAL1 SR7 with insertion of a CCW12 promoter insertion in front of TAL1 gene This study 
SR7 TPI1P-GND1 SR7 with insertion of a TPI1 promoter insertion in front of GND1 gene This study 
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Table 2.4. Guide RNA sequence synthesized as gBlocks (388 bp) 
Parts Sequence Length 
(bp) 
TAL1 guide RNA   
SNR52 promoter TCTTTGAAAAGATAATGTATGATTATGCTTTCACTCATATTTATACAGAAACTTGATGTTTTCTTTCGA
GTATATACAAGGTGATTACATGTACGTTTGAAGTACAACTCTAGATTTTGTAGTGCCCTCTTGGGCTA
GCGGTAAAGGTGCGCATTTTTTCACACCCTACAATGTTCTGTTCAAAAGATTTTGGTCAAACGCTGTA
GAAGTGAAAGTTGGTGCGCATGTTTCGGCGTTCGAAACTTCTCCGCAGTGAAAGATAAATGATC 
269 
TAL1 upstream target TCTCGAGTATATAATTTTTC 20 
Structural crRNA GTTTTAGAGCTAGAAATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCG
AGTCGGTGGTGC 
79 
SUP4 terminator TTTTTTTGTTTTTTATGTCT 20 
GND1 guide RNA   
SNR52 promoter TCTTTGAAAAGATAATGTATGATTATGCTTTCACTCATATTTATACAGAAACTTGATGTTTTCTTTCGA
GTATATACAAGGTGATTACATGTACGTTTGAAGTACAACTCTAGATTTTGTAGTGCCCTCTTGGGCTA
GCGGTAAAGGTGCGCATTTTTTCACACCCTACAATGTTCTGTTCAAAAGATTTTGGTCAAACGCTGTA
GAAGTGAAAGTTGGTGCGCATGTTTCGGCGTTCGAAACTTCTCCGCAGTGAAAGATAAATGATC 
269 
GND1 upstream target TGTAGTTTTTGTATAGAAAG 20 
Structural crRNA GTTTTAGAGCTAGAAATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCG
AGTCGGTGGTGC 
79 
SUP4 terminator TTTTTTTGTTTTTTATGTCT 20 
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Table 2.5. List of primers used in the study 
Name Sequence Description 
SOO209 5′-GCC GGATCC AAAAATGACTGCTCAACAAGGT-3´ PHO13_F (BamHI) 
SOO210 5′-GCC GTCGAC CTATAACTCATTATTGGTTAAGGT-3´ PHO13_R (SalI) 
SOO624 5′-ACTCGCGGGTTTTTCTTTTTTCTCAATTCTTGGCTTCCTCTTCACGCAAAAGAAAACCTT-3´ Donor_TAL1_CCW12-F 
SOO625 5′-AGCAACCTTTTGTTTCTTTTGAGCTGGTTCAGACATTATTGATATAGTGTTTAAGCGAAT-3´ Donor_TAL1_CCW12-R 
SOO672 5′-CGGGTTTTTCTTTTTTCTCAATTCTTGGCTTCCTCTTGCTACCTATATTCCACCATAACA-3´ Donor_TAL1_TEF2-F 
SOO673 5′-CAACCTTTTGTTTCTTTTGAGCTGGTTCAGACATGTTTAGTTAATTATAGTTCGTTGACC-3´ Donor_TAL1_TEF2-R 
SOO674 5′-ACTCGCGGGTTTTTCTTTTTTCTCAATTCTTGGCTTCCTCTTAATGACGGTCGTTTCACA-3´ Donor_TAL1_RPS13-F 
SOO675 5′-TGTTAGCAACCTTTTGTTTCTTTTGAGCTGGTTCAGACATTTTGACTGATTGTTGTTGAT-3´ Donor_TAL1_RPS13-R 
SOO701 5′-ACTCGCGGGTTTTTCTTTTTTCTCAATTCTTGGCTTCCTCTTCTGTTTGCTTTGTTCTGG-3´ Donor_TAL1_HFF1-F 
SOO702 5′-AGCAACCTTTTGTTTCTTTTGAGCTGGTTCAGACATACTATATTATATTTGTTGCTTGTT-3´ Donor_TAL1_HFF1-R 
SOO609 5′-CTGATACATATAAACCTGTATTGTTGCCATTACAGAAAAAAGAATGCCCTTCATGCCTCC-3´ Donor_GND1_ TPI1-F 
SOO610 5′-ACGGCCAAACCAATCAAACCGAAATCAGCAGACATTTTGAATATGTATTACTTGGTTATG-3´ Donor_GND1_ TPI1-R 
SOO599 5′-GCTATGTCACTAATGATCTCG-3´ GND1_confirmation-F (−1000 bp) 
SOO618 5′-TGATGGCAGTCCACTTAC-3´ GND1_confirmation-R (+802 bp) 
SOO626 5′-TTTCTCAATTCTTGGCTTCCTC-3´ TAL1_confirmation-F (−104 bp) 
SOO676 5′-AGACAATCTAGCATCAACTTCG-3´ TAL1_confirmation-R (+342 bp) 
SOO613 5′-GCCTTCTACGTTTCCATCCA-3´ RT-qPCR_ACT1-F 
SOO614 5′-GGCCAAATCGATTCTCAAAA-3´ RT-qPCR_ACT1-R 
SOO417 5′-CTGCTACTTATGGCTGGAAACT-3´ RT-qPCR_GND1-F 
SOO418 5′-GGTTCTTCTCTGTAGGCCTTTG-3´ RT-qPCR_GND1-R 
SOO365 5′-CCTCAAGACTCCACAACTAACC-3´ RT-qPCR_TAL1-F 
SOO366 5′-ACCATGCTTCTTACCGTATTCC-3´ RT-qPCR_TAL1-R 
Restriction enzyme sequences are underlined. 
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Figure 2.8. Aliphatic regions of the 1H spectra. (A) SR7 and (B) SR7 pho13Δ. sed, 
sedoheptulose; Thr, threonine; tre, trehalose; Lys, lysine; Glu, glutamic acid; Ala, alanine; Val, 
valine; Leu, leucine; Iie, isoleucine. 
 
 
 
 
 
 
 
 
 
 
 
34 
 
 
Figure 2.9. Clustered heat map of HCA for metabolomic profiles of SR7 and SR7 pho13Δ. 
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Figure 2.10. Linear correlation between theoretical promoter strength (relative to transcript 
abundance of the corresponding gene measured by RNA sequencing) and the empirical values 
(transcript abundance of the engineered TAL1 gene measured by RT-qPCR). RT-qPCR was 
performed with both biological and experimental triplicates; the error bars indicate the standard 
deviations. 
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Figure 2.11. Fold changes of PP pathway genes expression levels in the SR7 CCW12p-TAL1 
compared with SR7 in both glucose and xylose condition. The expression levels of the mutants 
and the control strain were measured by RT-qPCR. Error bars indicate standard deviations of 
three biological replicates. 
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CHAPTER 3: ENGINEERING SACCHAROMYCES CEREVISIAE TO CO-FERMENT 
GLUCOSE AND XYLOSE BY MUTANT GAL2 TRANSPORTERS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The content of this chapter is in preparation for submission. I was the first author of the paper, 
and Ching-Sung Tsai, Stephan Lane, Soo Rin Kim, and Yong-Su Jin, were co-authors. I 
performed the research with help from the co-authors, and Dr. Yong-Su Jin and Dr. Soo Rin Kim 
were the directors of the research. 
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3.1. Introduction  
Lignocellulosic biofuel production is widely believed to be a promising strategy to solve 
the energy crisis without hurting the food supply compared to biofuel generated from food 
sources (Stephanopoulos, 2007). Saccharomyces cerevisiae has been harnessed by human beings 
for the ethanol production for a long time. And it is currently being used for the production of 
ethanol from sugarcane because of its high tolerance to ethanol and fermentation inhibitors 
(Delgenes et al., 1996; Pereira et al., 2015). However, besides glucose, hydrolysates of 
lignocellulosic biomass consists of a decent amount of pentose. For example, 30% of the 
biomass in corn stover is xylose (Kim et al., 2012), which cannot be fermented by 
Saccharomyces cerevisiae naturally.  In order to achieve xylose utilization in Saccharomyces 
cerevisiae, heterologous xylose pathway from Scheffersomyces stipitis, including xylose 
reductase (XR) and xylitol dehydrogenase (XDH), were introduced into Saccharomyces 
cerevisiae (Kotter and Ciriacy, 1993; Takuma et al., 1991; Tantirungkij et al., 1993). However, 
XR prefers NADPH to NADH while XDH only can use NAD+ as a cofactor. Therefore, this will 
cause severe co-factor imbalance for xylose fermentation, leading to lower ethanol yield (Kim et 
al., 2013b; Rizzi et al., 1989; Verduyn et al., 1985). To bypass the redox-imbalance problem of 
the oxido-reductase pathway, people introduced xylose isomerase pathway from different 
sources into Saccharomyces cerevisiae (Brat et al., 2009; Kim et al., 2013b; Lee et al., 2014b; 
Vilela Lde et al., 2015; Young et al., 2014). 
 
Though engineered Saccharomyces cerevisiae is capable of fermenting glucose and 
xylose separately, the simultaneous co-utilization of glucose and xylose, which shows advantage 
in terms of higher ethanol yield and titer (Lynd et al., 2008), cannot be achieved yet. The major 
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hurdle for simultaneous co-fermentation of glucose and xylose is glucose repression, which can 
be dissected into glucose repression on xylose metabolism (Santangelo, 2006; Subtil and Boles, 
2012; Verstrepen et al., 2004) and glucose competitive inhibition on xylose transport (Farwick et 
al., 2014; Lee et al., 2002; Nijland et al., 2014; Young et al., 2014). Between them, transport 
inhibition was believed to be the more prominent problem (Subtil and Boles, 2012). Both 
heterologous sugar transporters, such as Gxf1 from Candida intermedia and Sut1 from 
Scheffersomyces stipites, and endogenous sugar transporters had been studied to enable co-
fermentation of glucose and xylose (Fonseca et al., 2011; Goncalves et al., 2014; Katahira et al., 
2008; Sedlak and Ho, 2004; Young et al., 2012). However, most of these transporters showed 
preference towards glucose over xylose. Consequently, many groups have tried to engineer a 
xylose specific transporter by both evolutionary engineering and rational approaches to achieve 
co-fermentation of glucose and xylose (Farwick et al., 2014; Nijland et al., 2014; Reznicek et al., 
2015; Young et al., 2011; Young et al., 2014). Young and his colleagues tried to wire the 
transporters’ preference by programming an identified sequence motif, G-G/F-XXX-G, which is 
common in most endogenous sugar transporters and heterologous sugar transporter (Young et al., 
2014). Their engineered transporters, including mutant Candida intermedia gxs1 
Scheffersomyces stipitis rgt2 and Saccharomyces cerevisiae hxt7, enabled transporters-null 
Saccharomyces cerevisiae to grow on xylose but not on glucose. Another study down by 
Farwick and his colleagues discovered two conserved residues in Saccharomyces cerevisiae 
glucose transporters where mutation of these two residues altered the transporters’ preference on 
glucose and xylose.(Farwick et al., 2014). Among those mutant transporters, they claimed that 
Gal2-N376F was able to transport xylose without inhibition by glucose, and Gal2-N376V 
showed relative weak inhibition by glucose (Farwick et al., 2014). However, neither of these two 
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studies demonstrated fast glucose and xylose co-fermentation by using their mutant transporters. 
One possible reason is that highly engineered transporters-null strains are not robust. 
Interestingly, one recent study showed that a widely used transporters-null Saccharomyces 
cerevisiae by LoxP/Cre system suffered from gene losses and chromosomal rearrangement 
(Solis-Escalante et al., 2015). 
Using a CRISPR/Cas9 based multiple-gene deletion technique, HXT1-7 and GAL2 were 
deleted in an engineered Saccharomyces cerevisiae strain with an efficient xylose metabolism 
pathway. The resulting strain could not grow on both glucose and xylose while, by 
complementation with sugar transporters, the strain retained efficient xylose and glucose 
fermentation ability. This is the first study showing the benefit of the Cas9 technique for rapid 
construction of sugar transport deficient Saccharomyces cerevisiae strain. Furthermore, by 
introducing previous reported GAL2 (Farwick et al., 2014) mutants into our sugar-transport-
deficient strain, we are able to achieve fast xylose and glucose co-fermentation. 
 
3.2. Materials and methods 
3.2.1. Strains and culture conditions 
All strains and plasmids used in this study were listed in Table 3.2. For testing sugar 
deleted strains (Fig. 3.2 and Fig. 3.7), yeast strains were pre-culture in 5 mL of YP medium (10 
g/L yeast extract, 20 g/L Bacto peptone) containing 2% ethanol aerobically at 30°C for 48 hours. 
For yeast strain harboring pRS41K serial plasmids (Fig. 3.2-3.6 and Fig. 3.8-3.9), yeast strains 
were pre-culture in 5 mL of YP medium (10 g/L yeast extract, 20 g/L Bacto peptone) containing 
40g/L xylose and 200 µg/ml Geneticin aerobically at 30°C for 24 hours. Then cells were 
harvested and washed twice with sterile water. For fermentation experiments, the initial cell 
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densities were adjusted to around OD = 1 (optical density at 600nm), which is about 0.47 g/L dry 
cell weight. Fermentation experiments were conducted under the oxygen-limited condition in 
125 mL flasks containing 25 mL medium at 30°C and 100 rpm.  
 
3.2.2. Plasmids and strains construction 
To construct pRS41K-TEF1P-GAL2-CYC1T plasmid, pRS41K--TEF1P- CYC1T was 
linearized with XmaI and EcoRV. Then the GAL2 gene was PCR from the CEN.PK genome 
with XmaI and EcoRV digestion site on each side. Next, the GAL2 gene fragment was digested 
with XmaI and EcoRV and then ligated with digested pRS41K-TEF1P-CYC1T vector. 
For cloning pRS41K-TEF1P-GAL2-F-CYC1T, pRS41K-TEF1P-GAL2-F-CYC1T, and 
single gRNA vectors, the Fast Cloning method (Li et al., 2011) was applied by using divergent 
overlapping primers (Table 3.3). 
To corporate multiple guide RNA cassettes into one plasmid, in vivo DNA assembler 
method was used with the help of yeast homologous recombination machinery according to the 
literature (Shao et al., 2009). After the colony PCR confirmation, desired colonies were cultured, 
and plasmids were extracted by using yeast plasmid extraction kit (Zymo Research, Irvine, CA). 
Then plasmids were re-transformed to E. coli for later enrichment. 
CRISPR/Cas9 guided deletions were performed according to previous literature (Zhang 
et al., 2014) with some modifications. For the deletion of four genes together, for example, 3 µg 
gRNA plasmid and 5 µg of each of four donors were added for each transformation.  
3.2.3. HPLC analysis 
Xylose and glucose concentrations during the fermentation were quantified by high-
performance liquid chromatography (HPLC) (Agilent, Santa Clara, CA) with the Rezex RCM- 
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Monosaccharide Ca+2 (8%) column (Phenomenex Inc., Torrance, CA). Glycerol, xylitol, 
acetate, and ethanol concentrations were quantified by HPLC with the Rezex ROA-Organic Acid 
H+ (8%) column (Phenomenex Inc., Torrance, CA). Samples were centrifuged first and the 
supernatant was used for analyzing. 
 
3.3. Results 
3.3.1. Construction and characterization of the sugar-transport-deficient Saccharomyces 
cerevisiae strain 
To test the sugar transporters’ ability to co-utilize glucose and xylose, a robust xylose-
fermenting Saccharomyces cerevisiae strain with major sugar transporters deletion is a 
prerequisite. HXT1-7 and GAL2 were deleted in a fast xylose-fermenting strain SR8 (Kim et al., 
2013c) by using the CRISPR/Cas9 guided multiple-gene deletion technique. The diagram for 
constructions of gRNA and deletion mutants were shown in Figure 3.1. For using the 
CRISPR/Cas9 technique to delete multiple genes at the same time, multiple guide RNA cassettes 
were cloned into one pRS42H or pRS42K vector by using yeast homologous recombination (Fig. 
3.1A). First HXT1-4 were completely deleted in xylose-fermenting Saccharomyces cerevisiae 
strain SR8, and then HXT5-7 were deleted. Finally, GAL2 was deleted. By doing this, a mutant 
SR8D8 with no glucose or xylose transportation ability was successfully constructed (Fig. 3.1C). 
 
The volumetric glucose consumption rate at 6 hour and the volumetric xylose 
consumption rate at 24 hour of parental strain SR8, SR8 HXT1-4∆, SR8 HXT5-7∆, SR8 HXT1-
7∆ and SR8D8 (SR8 HXT1-7∆ GAL2∆) were compared (Fig. 3.2A and 3.2B). After deletion of 
HXT1-4 or deletion of HXT5-7, strains still maintained xylose and glucose fermentation abilities 
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to a certain extent, while deletion of HXT1-7 almost reduced glucose and xylose consumption 
rate to zero. The growth of the parental strain SR8 (Fig. 3.2C) and the growth of SR8D8 (Fig. 
3.2D) strain in glucose, xylose, galactose and no sugar conditions were compared. The growth 
test clearly showed that SR8D8 grew at the same rate in xylose, glucose and galactose conditions 
as compared to no sugar condition. 
 
3.3.2. Restoration of xylose and glucose fermentation ability by introducing Gal2 
transporter  
To demonstrate that SR8D8 is an excellent platform strain for studying transporters, a 
Gal2 transporter was re-introduced into the SR8D8 strain by pRS41K plasmid with the TEF1 
promoter. After that, the strain retained its glucose and xylose consumption ability (Fig. 3.3A 
and 3B). Previously the deletion mutant, SR8 HXT1-7∆, which still had Gal2 transporter, could 
not grow in glucose condition. That was because of the glucose repression on GAL genes 
(Johnston et al., 1994; Lamphier and Ptashne, 1992). But, in this case, the constitutive promoter 
was used to express Gal2. Then in the mixture of 40 g/L xylose and 40g/L glucose, we could 
observe the sequential fermentation of glucose and xylose (Fig. 3.3C), which was typical for 
endogenous hexose transporters. The restoration of xylose and glucose fermentation abilities by 
introducing endogenous transporter proved the SR8D8’s potential for transporter study, 
especially for testing transporters for the co-fermentation of glucose and xylose. 
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3.3.3. Overexpression of Gal2-N376V in SR8D8 and the co-fermentation of glucose and 
xylose by SR8D8 41K-GAL2-V 
To achieve co-fermentation of glucose and xylose, a previously reported mutant Gal2 
transporter, Gal2-N376V (Young et al., 2014) with relatively weak inhibition from glucose, was 
overexpressed in SR8D8 by single copy plasmid with geneticin resistance. The resulting strain 
SR8D8 41K-GAL2-V retained efficient glucose and xylose fermentation abilities (Fig. 3.4A and 
4B). Then the mutant was tested for co-fermentation of glucose and xylose in 40 g/L xylose and 
40 g/L glucose mixture (Fig. 3.4C). Started with initial OD 1, the mutant was able to consume all 
the sugar within 36 hours under oxygen limited condition. Both sugars were consumed 
simultaneously though glucose was consumed faster than xylose. Comparison of SR8D8 41K-
GAL2-V and SR8D8 41K-GAL2 in 40 g/L xylose and 40 g/L glucose mixture showed that the 
mutant Gal2 transporter significantly reduced the lag phase of xylose consumption so that the 
total fermentation time was reduced, compared with the wild-type Gal2 transporter (Fig. 3.8). 
The co-fermentation was also achieved under industrially relevant condition with 70g/L glucose 
and 40g/L xylose (Fig. 3.4D). This result demonstrated the potential of using the Gal2-N376V 
transporter for co-fermentation in different ratios of glucose and xylose. 
 
3.3.4. Overexpression of Gal2-N376F in SR8D8 and the co-fermentation of glucose and 
xylose by the co-culture system 
It has been reported that mutant Gal2 transporter, Gal2-N376F (Young et al., 2014) could 
not support growth on glucose, and the xylose transport by this transporter would not be 
inhibited by glucose. To characterize this transporter, we overexpressed it in SR8D8 by single 
copy plasmid with geneticin resistance cassette. The resulting strain SR8D8 41K-GAL2-F could 
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consume glucose and grow in 40g/L glucose with initial OD 1 (Fig. 3.5A) indeed. But the 
glucose consumption rate was so slow that the generated ethanol was also used during the 
fermentation. More detailed examination showed that under lower concentrations of sugar with 
initial OD 0.1, the mutant could barely consume glucose (Fig. 3.9A and B). Then the mutant was 
also tested in 40g/L pure xylose, and a mixture of 40 g/L glucose and 40 g/L xylose (Fig. 3.5B 
and 3.5C). In the pure xylose condition, 40 g/L xylose was almost finished within 36 hours 
while, with the presence of glucose, the mutant took around 48 hours to finish all the xylose. 
Also, we could observe glucose reduction after 24 hours in the mixture of glucose and xylose. 
This result suggests that Gal2-N376F indeed can very slowly transport glucose, and the 
inhibition of glucose to xylose is present, but very weak. 
Since Gal2-N376F has very strong preference for xylose, we designed a co-culture 
system to use both SR8D8 41K-GAL2-F and D452 41K, which could consume glucose only 
(Fig. 3.5D and 3.5E), for the co-fermentation of glucose and xylose. The fermentation was 
performed with OD 1 inoculum of D452 41K and OD 10 inoculum of SR8D8 41K-GAL2-F, 
considering the relatively faster glucose fermentation rate. 70 g/L glucose and 40 g/L xylose 
could be co-consumed in around 22 hours. This result demonstrates the possibility of co-
fermentation of glucose and xylose by using the co-culture system. 
 
3.3.5. The combination effect of Gal2-N376F and Gal2-N376V in SR8D8  
Since Gal2-N376F transporter prefers xylose to glucose, introduction of this transporter 
into SR8D8 41K-GAL2-V may further improve the co-fermentation ability of this strain. Gal2-
N376F overexpression cassette with TEF1 promoter and CYC1 terminator was integrated into the 
genome of SR8D8 41K-GAL2-V by the CRISPR/Cas9 technique. The resulting strain SR8D8-F 
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41K-GAL2-V consumed both glucose and xylose much faster in mixture of glucose and xylose, 
compared with its parental strain SR8D8 41K-GAL2-V (Fig. 3.10), though the growth of these 
two strains were almost same. We further compared this co-fermenting strain with the original 
strain SR8 41K, which is a sequential fermenting strain. Both strains consumed 40 g/L glucose 
and 40 g/L xylose in around 24 hours (Fig. 3.6A and 3.6B). SR8D8-F 41K-GAL2-V and the 
original strain SR8 41K were next compared in the industrially relevant concentration of glucose 
and xylose mixture (Fig. 3.6C and 3.6D). The co-fermentation strained not only showed similar 
ethanol production rate, but also achieved similar yield as compared to the original strain (Table 
3.1). 
 
3.4. Discussion  
Finding new transporters to bypass the glucose inhibition at transport level is the key to 
achieve the co-fermentation of glucose and xylose. Hxt-null Saccharomyces cerevisiae strain, 
constructed by the Loxp/Cre system, was widely used for transporter studies, especially for the 
purpose of finding xylose transporters free from glucose repression (Farwick et al., 2014; Young 
et al., 2014). However, the deletion of all native transporters by the Loxp/Cre system caused 
gene loss and chromosome rearrangement. That’s probably why the previous study could not 
present rapid glucose and xylose co-fermentation phenotype, even if they created mutant 
transporters with less inhibition by glucose. In the current study, we demonstrated the advantages 
of using the CRISPR/Cas9 based multiple-gene deletion strategy to construct the sugar-transport-
deficient Saccharomyces cerevisiae strain. Maximally four transporters were deleted at once, 
showing the efficiency of CRISPR/Cas9 based gene-editing methods. More importantly, 
CRISPR/Cas9 based gene-editing methods are clear, which will not leave undesired scars in the 
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genome (Jakociunas et al., 2015; Mans et al., 2015; Ryan and Cate, 2014; Zhang et al., 2014). 
Interestingly, after deletion of HXT1-7, our mutant could not consume glucose and had very long 
lag time for xylose consumption (Fig. 3.7). After the further deletion of GAL2, the mutant 
(SR8D8) became sugar-transport-deficient, which proved to be a good platform strain for 
transporter study. Our SR8D8 strain retained robust glucose and xylose fermentation phenotypes 
as soon as we re-introduce Gal2 transporter. But the strain showed sequential fermentation 
phenotype, which was a proof of glucose repression at transport level by wild-type endogenous 
transporters.  
In this study, we demonstrated the feasibility of co-fermentation of glucose and xylose by 
introducing two mutant Gal2 transporters Gal2-N376F and Gal2-N376V. Though this two 
transporters had been reported before (Farwick et al., 2014), the inability of their platform strain 
to ferment xylose efficiently restricted the application of these two transporters for co-
fermentation of glucose and xylose. Here, by just introducing one transporter Gal2-N376V into 
our sugar-transport-deficient strain, we could achieve efficient glucose and xylose co-
fermentation even in the industrially relevant concentration (Fig. 3.4D). Also, characterization of 
Gal2-N376F transporter showed that it could transport glucose, but in a very slow rate, which 
contradicted the claim from Farwick’s study that this transporter could not transport glucose 
(Farwick et al., 2014). Moreover, the 41K-GAL2-F strain presented strong preference for xylose 
over glucose in the mixture of glucose and xylose (Fig. 3.5C). Wild-type D452-2 strain can only 
ferment glucose. So by co-culture of these two yeast strains, which possessed opposite sugar 
selectivity, we achieved co-fermentation of glucose and xylose. Although people have been 
using the co-culture of Saccharomyces cerevisiae and Scheffersomyces stipites, or Escherichia 
coli and Saccharomyces cerevisiae to produce ethanol from hexose and pentose (Ashoor et al., 
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2015; Eiteman et al., 2008; Karagoz and Ozkan, 2014; Taniguchi et al., 1997), this is the first 
time that the co-fermentation of glucose and xylose is achieved by using two Saccharomyces 
cerevisiae strains.  Notably, without a strain capable of selectively consuming xylose even with 
the presence of glucose, co-fermenting glucose and xylose by co-culturing two Saccharomyces 
cerevisiae strains would not be achievable. 
Although many recent studies focused on transporters engineering to co-ferment xylose 
and glucose, the fermentation time of their co-fermentation strain was much longer than the 
sequential fermentation by xylose-fermenting Saccharomyces cerevisiae strains without 
transporter engineering (Nijland et al., 2014; Reznicek et al., 2015; Wang et al., 2015). In our 
study, by the combination of Gal2-N376F and Gal2-N376V transporters, we enabled the co-
fermentation of glucose and xylose at a similar rate of the sequential fermentation by the parental 
strain. Also, the ethanol yields of co-fermentation and sequential fermentation were similar 
(Table 3.1). We envision that, by increasing and balancing copy numbers of Gal2-N376F and 
Gal2-N376V transporters, we may able to achieve even faster co-fermentation of glucose and 
xylose. 
Our study proved that a robust xylose-fermenting Saccharomyces cerevisiae strain with 
major hexose transporters deletion was the prerequisite for achieving rapid co-fermentation of 
glucose and xylose. By introducing mutant endogenous transporters with balanced preferences 
for xylose and glucose, co-fermentation of glucose and xylose was achieved in industrially 
relevant sugar concentration. 
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3.5. Tables  
Table 3.1. Comparison of ethanol yield and ethanol productivity during co-fermentation 
 
40 g/L glucose and 40 g/L xylose 70 g/L glucose and 40 g/L xylose 
Strain Ethanol Yield (g/g) 
Ethanol Productivity 
(g/L/h) 
Ethanol Yield (g/g) 
Ethanol Productivity 
(g/L/h) 
SR8 41K 0.380±0.000 1.194±0.009 0.389±0.002 1.788±0.018 
SR8D8 41K-GAL2 0.351±0.003 0.765±0.027 - - 
SR8D8 41K-GAL2-V 0.356±0.000 0.844±0.001 0.361±0.022 1.115±0.059 
SR8D8-F 41K-GAL2-V 0.378±0.004 1.217±0.018 0.376±0.001 1.584±0.001 
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3.6. Figures 
 
Figure 3.1. Diagram of the sugar-transport-deficient strain construction. (A) Plasmids harboring multiple guide RNA were constructed 
by homologous recombination. (B) Sequential deletion of HXT1-7 and GAL2 by the CRISPR/Cas9 technique. (C) Arbitrary 
illustration of sugar transport reduction by transporters deletion. 
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Figure 3.2. Characterization of transporters deletion mutants. (A) Volumetric glucose and (B) volumetric xylose consumption rates of 
transporters deletion mutants and control strain (SR8) were calculated at 6 hours and 24 hours respectively. Growth of (C) control 
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strain (SR8) and (D) the sugar-transport-deficient mutant (SR8D8) in complex medium with 40g/L glucose, 40g/L xylose, 40 g/L 
galactose and no sugar control were monitored. The results are the means of duplicate experiments; the error bars indicate standard 
deviations. 
 
 
Fig. 3.3. Restoration of sugar transport ability by introducing the Gal2 transporter in the sugar-transport-deficient mutant (SR8D8). 
Fermentation profiles of strain SR8D8 41K-GAL2  in (A) 40g/L Glucose, (B) 40g/L xylose and (C) the mixture of 40g/L glucose and 
40g/L xylose were monitored. The results are the means of duplicate experiments; the error bars indicate standard deviations. 
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Fig. 3.4. Characterization of the Gal2-N376V transporter. Fermentation profiles of strain SR8D8 41K-GAL2-V in (A) 40g/L Glucose, 
(B) 40g/L xylose, (C) the mixture of 40g/L glucose and 40g/L xylose, and (D) the mixture of 70g/L glucose and 40 g/L xylose were 
monitored. The results are the means of duplicate experiments; the error bars indicate standard deviations. 
54 
 
 
Fig. 3.5. Characterization of the Gal2-N376F transporter and co-fermentation by co-culture system. Fermentation profiles of strain 
SR8D8 41K-GAL2-F in (A) 40g/L Glucose, (B) 40g/L xylose, and  (C) the mixture of 40g/L glucose and 40g/L xylose were 
monitored. Fermentation profiles of strain D452-2 41K in (D) 40g/L Glucose and (E) 40g/L xylose were monitored. (E) Fermentation 
profile of the mixture of D452-2 41K with OD 1 and SR8D8 41K-GAL2-F with OD 10 in 70g/L glucose and 40 g/L xylose were 
monitored. The results are the means of duplicate experiments; the error bars indicate standard deviations. 
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Fig. 3.6. Comparison of SR8D8-F 41K-GAL2-V with control strain (SR8 41K). Fermentation profiles of (A) SR8 41K and (B) 
SR8D8-F 41K-GAL2-F in the mixture of 40g/L Glucose and 40g/L xylose were compared. Fermentation profiles of (C) SR8 41K and 
(D) SR8D8-F 41K-GAL2-F in the mixture of 70g/L Glucose and 40g/L xylose were compared. The results are the means of duplicate 
experiments; the error bars indicate standard deviations. 
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3.7. Supplementary materials 
Table 3.2. List of plasmids and strains used in the study 
Plasmid or Strain Description Reference 
Plasmids   
pRS41N-Cas9 A single-copy plasmid containing Cas9 and a natMX marker  (Zhang et al., 2014) 
pRS42H A multi-copy plasmid containing a Hygromycin B marker UROSCARF 
pRS42H-gRNA-HXT1 (pCST161) A multi-copy plasmid containing a guide RNA for HXT1 deletion and a Hygromycin B marker  This study 
pRS42H-gRNA-HXT2 (pCST162) A multi-copy plasmid containing a guide RNA for HXT2 and a Hygromycin B marker This study 
pRS42H-gRNA-HXT3 (pCST163) A multi-copy plasmid containing a guide RNA for HXT3 and a Hygromycin B marker  This study 
pRS42H-gRNA-HXT4 (pCST164) A multi-copy plasmid containing a guide RNA for HXT4 and a Hygromycin B marker This study 
pRS42H-gRNA-HXT5 (pCST165) A multi-copy plasmid containing a guide RNA for HXT5 and a Hygromycin B marker  This study 
pRS42H-gRNA-HXT6 (pCST166) A multi-copy plasmid containing a guide RNA for HXT6 and a Hygromycin B marker This study 
pRS42H-gRNA-HXT7 (pCST167) A multi-copy plasmid containing a guide RNA for HXT7 and a Hygromycin B marker  This study 
pRS42K-gRNA-GAL2 A multi-copy plasmid containing a guide RNA a for GAL2 and a Geneticin marker This study 
pRS42H-gRNA-HXT1-4 A multi-copy plasmid containing four guide RNA and a Hygromycin B marker This study 
pRS42H-gRNA-Int A multi-copy plasmid containing a guide RNA for integration and a Hygromycin B marker This study 
pRS42K-gRNA-HXT5-7 A multi-copy plasmid containing three guide RNA and a Geneticin marker This study 
pRS41K A single-copy plasmid containing a Geneticin marker UROSCARF 
pRS41K-TEF1P-CYC1T A single-copy plasmid containing a Geneticin marker and TEF1 promoter and CYC1 terminator This study 
pRS41K-TEF1P-GAL2-CYC1T GAL2 under the control of TEF1 promoter in pRS41K This study 
pRS41K-TEF1P-GAL2-F-CYC1T GAL2-N376F under the control of TEF1 promoter in pRS41K This study 
pRS41K-TEF1P-GAL2-V-CYC1T GAL2-N376F under the control of TEF1 promoter in pRS41K This study 
Strains   
SR8 S. cerevisiae D452-2 with a xylose pathway (S. stipitis XYL1, XYL2, and XYL3), PHO13∆, ALD6∆ (Kim et al., 2013c) 
   SR8 pRS41N-Cas9 SR8 with Cas9 protein expressing plasmid This study 
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   SR8 41K SR8 with pRS41K empty vector This study 
SR8 HXT1-4∆ SR8 with HXT1-4 deletion This study 
SR8 HXT5-7∆ SR8 with HXT5-4 deletion This study 
SR8 HXT1-7∆ SR8 with HXT1-7 deletion This study 
SR8 HXT1-7∆GAL2∆ (SR8D8) SR8 with HXT1-7 and GAL2 deletion This study 
SR8D8 41K-GAL2 SR8D8 with pRS41K-TEF1P-GAL2-CYC1T This study 
SR8D8 41K-GAL2-F SR8D8 with pRS41K-TEF1P-GAL2-F-CYC1T This study 
SR8D8 41K-GAL2-V SR8D8 with pRS41K-TEF1P-GAL2-V-CYC1T This study 
SR8D8-F  SR8D8 with GAL2-N376F integration This study 
SR8D8-F 41K-GAL2-V SR8D8-F with pRS41K-TEF1P-GAL2-V-CYC1T This study 
Table 3.2 (cont.) 
 
Table 3.3. List of primers used in the study 
Name Sequence (5’→3’) Description 
SOO743 GCC CCCGGG AAAA ATGGCAGTTGAGGAGAACAATATG GAL2_for_XmaI 
SOO744 GGC GATATC TTATTCTAGCATGGCCTTGTACC GAL2_rev_EcoRV 
SOO759 TAGTCTTCTTTGCCTCCACTTTCTTTAG GAL2_N376F_for 
SOO760 GCAAAGAAGACTACACCAATGACAATGG GAL2_N376F_rev 
SOO761 TAGTCGTCTTTGCCTCCACTTTCTTTAG GAL2_N376V_for 
SOO762 GCAAAGACGACTACACCAATGACAATGG GAL2_N376V_rev 
Jin3262 TCATGTTCTTTCCCCACCTTAAAATCTATAAAGATATCATAATCGTCAACTAGTTGATATACGTA
AAATCCGGTTTCTGTTGGTCGTAGA 
HXT1_donor_for 
Jin3263 CTTTATAAAATTTACTGAGAAATTAAATACTGTATAAGTCATTAAAATATGCATATTGAGCTTGT
TTAGTTCTACGACCAACAGAAACCG 
HXT1_ donor_rev 
Jin3266 TCTCAATTCCTCTTATATTAGATTATAAGAACAACAAATTAAATTACAAAAAGACTTATAAAGC
AACATACGAGCGACTCGATGATCAAC 
HXT2_ donor_for  
Jin3267 GAAGATCATCTATTAAAGTATTAGTAGCCATTAGCCTTAAAAAAATCAGTGCTAGTTTAAGTAT
AATCTCGTTGATCATCGAGTCGCTCG 
HXT2_ donor_rev 
Jin3343 ATAATTTTACTTAATAGCTTTTCATAAATAATAGAATCACAAACAAAATTTACATCTGAGTTAAA
CAATCACGATGCTGAAGGCTCAGGT 
HXT3_ donor_for 
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Jin3344 TTTATCATTATTGACTAGCACATCGAATCTTAAAATACACTATTATTCAGCACTACGGTTTAGCG
TGAAAACCTGAGCCTTCAGCATCGT 
HXT3_ donor_rev 
Jin3347 GAAAAGATATATTCAAAGCCTCTTATCAAGGTTTGGTTTTGAAACACTTTTACAATAAAATCTGC
CAAAATCATGCATCGTTCCACTGTG 
HXT4_ donor_for 
Jin3348 GCGTTAAAAATTGAAGATCAAATATTATTTTTATTCCTTGAAGGAAGTCTATATTATTTAATTAA
CTGACCACAGTGGAACGATGCATGA 
HXT4_ donor_rev 
Jin3454 ATAGCTTTGTTAAAACCAGCAAAAAATATTATTTTTCTAGAAAAAAGAATATATTAGAGGTAAA
GAAAGATTGTACACCTACCGGTCACC 
HXT5_ donor_for 
Jin3455 TAAAATTTGAAATGGTGCAATGCTGAACATTGCAAGTATGCGAAAATAGTTGATCCTACACTAC
AAGAGAGGTGACCGGTAGGTGTACAA 
HXT5_ donor_rev 
Jin3458 AGTTTTTTTCCTTTAAACGCTGGAAAAAAAGGAGAAATTATTGGAACTTTGCAGAGAATAGTCC
GTAGGCGACTGTCTATCGGCTAGG 
HXT6&7_ donor_for 
SOO724   CTGCAGGCAAAATTGGAATATTTGTGAATAACAGTGCGGTCGGTAAACAACTGACTTCTTCCCA
CTTTGCGACCTAGCCGATAGACAGTC 
HXT6&7_ donor_rev 
Jin3466 
ATTATCATCAAGAATAGTAATAGTTAAGTAAACACAAGATTAACATAATAAAAAAAATAATTCT
TTCATACTGACCTAGATGCAATGACG GAL2_ donor _for 
Jin3467 
ATTAAAATGAAGAAAAAACGTCAGTCATGAAAAATTAAGAGAGATGATGGAGCGTCTCACTTC
AAACGCACGTCATTGCATCTAGGTCAG GAL2_ donor _rev 
SOO587 AACCTCGAGGAGAAGTTTTTTTACCCCTCTCCACAGATC CAGGAAACAGCTATGACCATG Int1_donor_for 
SOO588 TAATTAGGTAGACCGGGTAGATTTTTCCGTAACCTTGGTGTC TGTAAAACGACGGCCAGT Int1_donor_for 
SOO728 AAACTAGGAAGAAATGCTGC HXT1_confirm_for 
SOO729 CGACTCGGTTATCTGTTAATG HXT1_confirm_rev  
SOO632 GTTGACAGGTCAGTTAAGGCACAG HXT2_confirm_for  
SOO633 GTTGATCATCGAGTCGCTCG HXT2_confirm_rev 
Jin3345 GCAGACAGCCTTCATCTTCTCG HXT3_confirm_for 
Jin3346 ACCTGAGCCTTCAGCATCGT HXT3_confirm_rev 
Jin3349 CAAGAAACGCTTGGCCTTCG HXT4_confirm_for 
Jin3350 CACAGTGGAACGATGCATGA HXT4_confirm_rev 
Jin3456 GTTATGTTAAGGTCTCCGATACG HXT5_confirm_for 
Jin3457 GGTGACCGGTAGGTGTACAA HXT5_confirm_rev 
Jin3460 GCTTACTCAGACACCAACAC HXT6&7_confirm_for 
Jin3461 GACCTAGCCGATAGACAGTC HXT6&7_confirm_rev 
Jin3468 CAAGACGACAGTAATATGTCTCC GAL2_confirm_for 
Jin3469 CGTCATTGCATCTAGGTCAG GAL2_confirm_rev 
SOO595 GTCTGCCGAAATTCTGTG  Int1_confirm_for 
SOO598 CGGTCAGAAAGGGAAATG  Int1_confrom_rev 
SOO601 TTTGTGGACTGTCGAAAACT GTTTTAGAGCTAGAAATAGCAAGTT gRNA plasmid GAL2 Forward 
SOO602 AGTTTTCGACAGTCCACAAA GATCATTTATCTTTCACTGCGGAGA gRNA plasmid GAL2 Reverse 
Table 3.3 (cont.) 
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CST515 TGTGTTATGGTTGCTTTCGGGTTTTAGAGCTAGAAATAGCAAGTTAAA pCST161 HXT1 Forward 
CST516 ACCCGAAAGCAACCATAACACAGATCATTTATCTTTCACTGCGGA pCST161 HXT1 Reverse 
CST517 TGTGTTATGGTTGCTTTCGG pCST161 Check 
CST518 CAAAGCCAATCGCCGCATATGTTTTAGAGCTAGAAATAGCAAGTTAAA pCST162 HXT2 Forward 
CST519 ACATATGCGGCGATTGGCTTTGGATCATTTATCTTTCACTGCGGA pCST162 HXT2 Reverse 
CST520 CAAAGCCAATCGCCGCATAT pCST162 Check 
CST521 CCTGCCTTCGAATAGCTCTCGTTTTAGAGCTAGAAATAGCAAGTTAAA pCST163 HXT3 Forward 
CST522 ACGAGAGCTATTCGAAGGCAGGGATCATTTATCTTTCACTGCGGA pCST163 HXT3 Reverse 
CST523 CCTGCCTTCGAATAGCTCTC pCST163 Check 
CST524 AATTAGAATCGGATTCAACGTTTTAGAGCTAGAAATAGCAAGTTAAA pCST164 HXT4 Forward 
CST525 ACGTTGAATCCGATTCTAATTGATCATTTATCTTTCACTGCGGA pCST164 HXT4 Reverse 
CST526 AATTAGAATCGGATTCAAC pCST164 Check 
CST527 TCAGGAAACTCGACTGCTCCGTTTTAGAGCTAGAAATAGCAAGTTAAA pCST165 HXT5 Forward 
CST528 ACGGAGCAGTCGAGTTTCCTGAGATCATTTATCTTTCACTGCGGA pCST165 HXT5 Reverse 
CST529 TCAGGAAACTCGACTGCTCC pCST165 Check 
CST530 CAACTACGACGCTGAAGAAAGTTTTAGAGCTAGAAATAGCAAGTTAAA pCST166 HXT6 Forward 
CST531 ACTTTCTTCAGCGTCGTAGTTGGATCATTTATCTTTCACTGCGGA pCST166 HXT6 Reverse 
CST532 CAACTACGACGCTGAAGAAA pCST166 Check 
CST533 GTCGTAGTTGGCACCTCTTCGTTTTAGAGCTAGAAATAGCAAGTTAAA pCST167 HXT7 Forward 
CST534 ACGAAGAGGTGCCAACTACGACGATCATTTATCTTTCACTGCGGA pCST167 HXT7 Reverse 
CST535  GTCGTAGTTGGCACCTCTTC pCST167 Check 
CST561 GCCAGAGGTATAGACATAGCCAGACCTACCTAATTGGTGCATCAGGTGGTCATGGCCCTTCCT 
GTGTGAAATTGTTATCCGC 
Primer with linker sequence 
CST562 GTGCCTATTGATGATCTGGCGGAATGTCTGCCGTGCCATAGCCATGCCTTCACATATAGTAACG 
TCGTGACTGGGAAAAC 
Primer with linker sequence 
CST563 ACTATATGTGAAGGCATGGCTATGGCACGGCAGACATTCCGCCAGATCATCAATAGGCACCAG 
GAAACAGCTATGAC 
Primer with linker sequence 
CST564 GTTGAACATTCTTAGGCTGGTCGAATCATTTAGACACGGGCATCGTCCTCTCGAAAGGTGGTAA
AACGACGGCCAG 
Primer with linker sequence 
CST565 CACCTTTCGAGAGGACGATGCCCGTGTCTAAATGATTCGACCAGCCTAAGAATGTTCAACCAG 
GAAACAGCTATGAC 
Primer with linker sequence 
CST566 CTAGCGTGTCCTCGCATAGTTCTTAGATTGTCGCTACGGCATATACGATCCGTGAGACGTGTAA 
AACGACGGCCAG 
Primer with linker sequence 
CST567 ACGTCTCACGGATCGTATATGCCGTAGCGACAATCTAAGAACTATGCGAGGACACGCTAGCAG 
GAAACAGCTATGAC 
Primer with linker sequence 
CST568 AATCACTCTCCATACAGGGTTTCATACATTTCTCCACGGGACCCACAGTCGTAGATGCGTGTAA 
AACGACGGCCAG 
Primer with linker sequence 
Table 3.3 (cont.) 
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CST569 ACGCATCTACGACTGTGGGTCCCGTGGAGAAATGTATGAAACCCTGTATGGAGAGTGATTCAG 
GAAACAGCTATGAC 
Primer with linker sequence 
CST572 AAGGGCCATGACCACCTGATGCACCAATTAGGTAGGTCTGGCTATGTCTATACCTCTGGCGTAA
AACGACGGCCAG 
Primer with linker sequence 
Table 3.3 (cont.) 
 
Figure 3.7. (A) Glucose consumption and (B) xylose consumption of transporters deletion mutants and control strain (SR8) were 
compared. The results are the means of duplicate experiments; the error bars indicate standard deviations. 
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Figure 3.8. Fermentation profiles of SR8D8 41K-GAL2-V (solid line with square) and SR8D8 41K-GAL2 (dash line with circle) in 
the mixture of 40 g/L glucose and 40 g/L xylose were compared. The results are the means of duplicate experiments; the error bars 
indicate standard deviations. 
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Figure 3.9. (A) Growth and (B) glucose consumption of SR8D8 41K-GAL2-F in different glucose concentrations were compared. The 
results are the means of duplicate experiments; the error bars indicate standard deviations. 
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Figure 3.10. Fermentation profiles of SR8D8-F 41K-GAL2-V (solid line with square) and SR8D8 41K-GAL2-V (dash line with 
circle) in the mixture of 40 g/L glucose and 40 g/L xylose were compared. The results are the means of duplicate experiments; the 
error bars indicate standard deviations.
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CHAPTER 4: CONCLUSIONS AND FUTURE WORK 
4.1. Conclusions 
4.1.1 Study for improving xylose metabolism 
After the introduction of heterologous xylose-assimilating pathway, Saccharomyces 
cerevisiae always suffered from the inefficient xylose metabolism, which could be relieved by 
pho13Δ. Our metabolomics study showed that sedoheptulose and sedoheptulose-7-phophate 
(S7P) accumulated in the slow xylose-fermenting strain. However, pho13Δ significantly reduced 
the accumulation of these two intermediates. This result revealed the unique metabolic pattern of 
Saccharomyces cerevisiae during xylose fermentation. 
S7P is the substrate of transaldolase (Tal1), and our previous study showed that pho13Δ 
could up-regulate the expression of several PP pathway genes, including TAL1. Therefore, we 
used the Cas9-guided promoter substitution technique to modulate TAL1 expression level. The 
strengths of promoters for substitution were selected according to the RNA sequencing results of 
the parental strain. Interestingly, the TAL1 expression levels of all the mutants strain with the 
promoter substitution showed a perfect correlation with their theoretical promoter strengths 
according to the RT-qPCR results. This correlation proved that coupling the Cas9-guided 
promoter substitution technique with RNA-seq based promoters probing worked efficiently for 
modulating target gene expression. 
Moreover, the phenotypic characterization of these mutants showed that TAL1 expression 
was positively correlated with xylose consumption rate but negatively correlated with 
sedoheptulose and S7P accumulation, which substantiated our hypothesis that TAL1 up-
regulation induced by pho13Δ deletion was the primary machinery for reducing sedoheptulose 
and S7P accumulation and improving xylose metabolism.  
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Notably, if we modulated TAL1 expression level to the same level as induced by pho13Δ, 
the resulting strain did not consume xylose as fast as the pho13Δ strain. Only when we 
excessively overexpressed TAL1, the resulting strain could consume xylose as fast as the pho13Δ 
strain. This result suggested that there might be other effects caused by pho13Δ that contributed 
to xylose metabolism. Therefore, GND1, which was the most up-regulated gene by pho13Δ, was 
overexpressed in slow xylose-fermenting strain. However, we did not observe any significant 
phenotypic changes with confirmed GND1 overexpression. This result confirmed that the 
metabolic change in pho13Δ strain was not caused solely by GND1 up-regulation.  
Finally, the catalytic activity of Pho13 was examined, which showed that Pho13 had non-
specific phosphatase activity on all PP pathway intermediates including S7P. This result 
suggested that when S7P is accumulated significantly in the slow xylose-fermenting strain, the 
non-specific phosphatase, Pho13, might dephosphorylate them to sedoheptulose, which was a 
dead end molecule inside of the cell. This conversion would cause carbon loss and waste energy 
so that the strain could not ferment xylose optimally. 
 
4.1.2. Study for the co-fermentation of glucose and xylose 
In this study, we constructed a sugar-transport-deficient xylose-fermenting strain by the 
Cas9-guided multiple-gene deletion technique. HXT1-7 and GAL2 were deleted during the 
process of strain construction. The deletion of HXT1-4 or HXT5-7 did not hamper the xylose or 
glucose transport a lot. But the deletion of HXT1-7 almost destroyed the transport of both sugars.  
The sugar-transport-deficient strain retained efficient xylose and glucose metabolism by 
the overexpression of the Gal2 transporter, which suggested that the serial deletions of 
transporters did not cause side effects on the sugar metabolism. In the mixture of glucose and 
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xylose, the Gal2 overexpression strain showed sequential fermentation phenotype, which was 
common among wild-type hexose transporters in Saccharomyces cerevisiae. 
Furthermore, mutant hexose transporter Gal2-N376V or Gal2-N376F was overexpressed 
in the sugar-transport-deficient strain for characterizations. On one hand, the strain with Gal2-
N376V transporter co-fermented glucose and xylose efficiently in different ratios of glucose and 
xylose. On the other hand, the strain with Gal2-N376V transporter showed strong selectivity 
towards xylose. Thus, we used this strain and another yeast strain, with strong selectivity towards 
glucose, to build a co-culture system for the co-fermentation of glucose and xylose. 
Finally, we demonstrated the feasibility of co-fermentation of glucose and xylose with a 
similar rate as sequential fermentation of parental strain by combining Gal2-N376V transporter 
and Gal2-N376F transporter in our sugar-transport-deficient strain. 
 
4.2. Future work 
Since TAL1 up-regulation could not completely explain the beneficial effects of pho13Δ 
on the xylose metabolism, further study is required to examine factors besides TAL1 up-
regulation that contribute to xylose metabolism by  pho13Δ, which may provide new gene targets 
for improving xylose metabolism. 
Glyceraldehyde-3-P (G3P) is the substrate for transaldolase, which couples with S7P. 
However, G3P is also the substrate for Glyceraldehyde-3-phosphate dehydrogenase. So low 
expression level of TAL1 means inferiority of PP pathway for competing G3P with glycolysis. It 
is worthwhile to investigate how pho13 represses TAL1 expression in the natural Saccharomyces 
cerevisiae, which may shed some light on the indigenous priority of different metabolic 
pathways. 
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We also examined the GND1 expression levels of our best TAL1 overexpression mutant 
and control strain in both glucose and xylose condition. Interestingly we found the GND1 
expression level of our TAL1 overexpression mutant is as same as the control strain in glucose 
condition but significantly higher in xylose condition. Since Gnd1 is the enzyme that converts 
NADP+ to NADPH and the cofactor imbalance problem of xylose metabolism generates surplus 
NADP+, it is possible that the expression level of GND1 was regulated by the concentration of 
NADP+. Further study on this topic is also promising. 
Apart from major hexose transporters Hxt1-7 and Gal2, there are other cryptic 
transporters presence in the Saccharomyces cerevisiae. It would be safer to delete all the 
remaining transporters completely to create a real transporters null strain so that there is no risk 
that these cryptic transporters will be induced by any chance. 
Previous studies reported that Gal2 transporter would degrade through ubiquitination 
when the cells grow on glucose. So ensuing investigation is needed to study the degradation of 
our mutant Gal2 transporter during the co-fermentation of glucose and xylose and its influence 
on the co-fermentation.  
In order to further improve our co-fermentation strain, modulating and balancing the 
promoter strengths or copy numbers of those two mutant transporters are required. To achieve 
perfect simultaneous co-fermentation of glucose and xylose, the ratio of the abundance of those 
two mutant transporters is critical. 
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